Jeannette Potts - 28 Feb 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc.

Role
Officer Title: SVP, General Counsel and Corporate Secretary
Signature
/s/ Jeannette Potts
Issuer symbol
N/A
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 16:10:26 UTC
Previous filing
25 Feb 2022
Next filing
14 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FMTX Common Stock Award $0 +25,000 +112% $0.000000 47,358 28 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FMTX Stock Option (Right to Buy) Award $0 +37,500 $0.000000 37,500 28 Feb 2022 Common Stock 37,500 $9.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2 25% of the shares subject to the stock option shall vest on February 28, 2023, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.

Remarks:

Officer Title: SVP, General Counsel and Corporate Secretary